<p>A, Weight of female mice. B, Weight of male mice. Disease onset was calculated retrospectively as the day the mouse reached peak body weight. Disease onset was significantly earlier in both male and female SOD1 DJ-1 KO mice as compared to SOD1 mice (C, female mice; D, male mice). Data is presented as averages ± SE. * p<0.05, ** p<0.01. n = SOD1 mice 9F and 9M, SOD1 DJ-1 KO mice 14F and 22M.</p
<p>Group average change from initial body weight (top panels) and neurological disease severity scor...
<p>(A, B) Body weight (BW) of female (A) and male mice (B) fed a high-fat diet (HFD) or a standard-f...
<p>Histograms from Kaplan-Meier analysis showing the duration of the early phase (A) and the end sta...
<p>Given are parameters for disease onset (A-C), and survival (D) for the SOD-1 (G93A) (n = 17) and ...
<p>Accelerated deterioration of gait was observed in SOD1 DJ-1 KO mice as compared to SOD1 mice. The...
<p>The motor function and deterioration was evaluated by Rotarod (A, female mice; B, male mice). The...
<p>Kaplan-Meier survival curves of (A) male and female SOD1 DJ-1 KO mice and SOD1 mice.(B) The avera...
<p>(A) The SOD-1 (G93A)<sup>PS</sup> mice (n = 8) have a delayed onset of weight decrease when compa...
<p>(A) Motor signs (hind limb tremors) were measured with the clinical scoring system (see methods)....
(A) Increased body weight in female mice MARCH1-deficient mice (KO) compared to wildtype mice (WT) o...
<p>(A) Body weight of male mice. (B) Body weight of female mice. (C) Average daily food intake. (D) ...
<p>There was no significant difference in body weight of SOD1-G93A mice between the different diet g...
<p>(<b>a</b> and <b>d</b>) Total body mass; (<b>b</b> and <b>e</b>) fat mass; and (<b>c</b> and <b>f...
<p>The difference in neurological score was significant between the control group (SD) and KD group ...
<p>(A) Control and MB-treated (3, 10, 30 and 100 mg oral per kg body weight per day) SOD1<sup>G93A</...
<p>Group average change from initial body weight (top panels) and neurological disease severity scor...
<p>(A, B) Body weight (BW) of female (A) and male mice (B) fed a high-fat diet (HFD) or a standard-f...
<p>Histograms from Kaplan-Meier analysis showing the duration of the early phase (A) and the end sta...
<p>Given are parameters for disease onset (A-C), and survival (D) for the SOD-1 (G93A) (n = 17) and ...
<p>Accelerated deterioration of gait was observed in SOD1 DJ-1 KO mice as compared to SOD1 mice. The...
<p>The motor function and deterioration was evaluated by Rotarod (A, female mice; B, male mice). The...
<p>Kaplan-Meier survival curves of (A) male and female SOD1 DJ-1 KO mice and SOD1 mice.(B) The avera...
<p>(A) The SOD-1 (G93A)<sup>PS</sup> mice (n = 8) have a delayed onset of weight decrease when compa...
<p>(A) Motor signs (hind limb tremors) were measured with the clinical scoring system (see methods)....
(A) Increased body weight in female mice MARCH1-deficient mice (KO) compared to wildtype mice (WT) o...
<p>(A) Body weight of male mice. (B) Body weight of female mice. (C) Average daily food intake. (D) ...
<p>There was no significant difference in body weight of SOD1-G93A mice between the different diet g...
<p>(<b>a</b> and <b>d</b>) Total body mass; (<b>b</b> and <b>e</b>) fat mass; and (<b>c</b> and <b>f...
<p>The difference in neurological score was significant between the control group (SD) and KD group ...
<p>(A) Control and MB-treated (3, 10, 30 and 100 mg oral per kg body weight per day) SOD1<sup>G93A</...
<p>Group average change from initial body weight (top panels) and neurological disease severity scor...
<p>(A, B) Body weight (BW) of female (A) and male mice (B) fed a high-fat diet (HFD) or a standard-f...
<p>Histograms from Kaplan-Meier analysis showing the duration of the early phase (A) and the end sta...